| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 1791 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 2615 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 168803 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 80515 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 44231 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 69179 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 56082 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 201914 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 93782 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 9563 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 826 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 6706 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 4818 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 10719 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 2056 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 1222 | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 1454 units | |
| Integra Lifesciences Corporation | UDI-DI | 2024-09-20 | Class II | Nonconforming Material/Component | Identified higher-than-expected levels of endotoxin within the raw material used to produce Codman Surgical Patties and Strips that may have resulted in out-of-specification levels of endotoxin in finished goods | 3494 units | |
| Cerenovus, Inc. | 510(k) number | 2010-07-16 | Not classified | Process control | Surgical Pattie x-ray stripe (radio-opaque marker) became detached | 673 boxes (20 pouches of 10 patties per box) | 2012-07-09 |
| Cerenovus, Inc. | 510(k) number | 2010-07-16 | Not classified | Process control | Surgical Pattie x-ray stripe (radio-opaque marker) became detached | 4407 boxes (20 pouches of 10 patties) | 2012-07-09 |
| Cerenovus, Inc. | 510(k) number | 2010-07-16 | Not classified | Process control | Surgical Pattie x-ray stripe (radio-opaque marker) may become detached | 229 boxes (100 cards/10 patties each card) | 2012-07-09 |